GENB Generate Biomedicines leadership flags accelerated AI drug pipeline advancement as top priority in latest quarterly earnings update Is Aktis AKTS stock outperforming similar companies Risk Aversion 20260427 What market slippage Helmerich HP Helmerich swings to loss misses EPS by 2456